Physician profile
Robert Vaclav
NPI 1205880192
$4,809.33
in general payments reported to CMS, 2019-2025
50 companies · $1,106 in 2025
The $1,106 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $260 · 2021: $815 · 2022: $590 · 2023: $810 · 2024: $1,032 · 2025: $1,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,947.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $661.17 | 2019-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Abbvie INC. | $647.28 | 2019-2025 | Vraylar, Linzess, Viberzi |
| Pfizer INC. | $622.77 | 2019-2025 | |
| Lilly USA, LLC | $388.12 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $219.16 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $208.33 | 2019-2025 | Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $204.49 | 2021-2025 | Capvaxive, Gardasil 9, Verquvo |
| Janssen Pharmaceuticals, INC | $147.63 | 2021 | |
| Janssen Biotech, INC. | $142.94 | 2020-2021 | |
| Abbott Laboratories | $111.09 | 2022-2025 | Freestyle Libre 3 |
| Boston Scientific Corporation | $104.96 | 2019-2025 | General - Pain Management |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.76 | 2020-2025 | Xifaxan |
| Biohaven Pharmaceuticals, INC. | $76.36 | 2021 | |
| Exact Sciences Corporation | $71.89 | 2024-2025 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $69.70 | 2023 | Quviviq |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Vaclav listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.